News > Five COVID-19 vaccines likely by end of Q3; Sputnik V, Novavax, J&J in line
Five COVID-19 vaccines likely by end of Q3; Sputnik V, Novavax, J&J in line
Business Today | 11/04/2021 05:02 PM | Click to read full article
The vaccines are Sputnik V vaccine (in collaboration with Dr. Reddy's), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila's vaccine, and Bharat Biotech's Intranasal Vaccine.
Russian Direct Investment Fund (RDIF) has tied up with a host of Indian pharma companies for the production of Sputnik V.
